Lau-Min et al. (2024). Association between oral targeted cancer drug net health benefit, uptake, and spending.

Association between oral targeted cancer drug net health benefit, uptake, and spending.

Lau-Min, KS., Wu, X., Rochester, S., Bekelman, JE., Kanter, GP., Getz, KD.

JNCI: Journal of the National Cancer Institute, Volume 116, Issue 9, September 2024, Pages 1479–1486, https://doi.org/10.1093/jnci/djae110

 

by Sylvia Spengler-Mettler

Masiero et al. (2024). Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer.

Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer.

Masiero, M., Spada, G.E., Fragale, E., · Pezzolato, M., Munzone, E., Sanchini, V.,· Pietrobon, R., Teixeira, L., Valencia, M., Machiavelli, A., Woloski, R., Marzorati, C., Pravettoni, G. https://doi.org/10.1007/s00520-024-08639-4

by Sylvia Spengler-Mettler

Dang et al. (2024). Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol.

Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol.

Dang,TH., Wickramasinghe, N., Jayaraman, P., Burbury, K., Alexander, M., Whitechurch, A., Quinne, St., Rowan, G., Brooks, SL., Schofield, P.

https://doi.org/10.1136/bmjopen-2023-079122

by Sylvia Spengler-Mettler

Rinder et al. (2024). Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer.

Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer.

Rinder, P., Théo Marcille, T., Sinel-Boucher, P., Cals-Maurette, M., Kanoun, D., Levy, Ch., Teixeira, L., Hornus, P., Szeftel, D., Heudel, P.-E.

Doi: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2818949

by Sylvia Spengler-Mettler

Wheeler at al. (2024). Sticking to the script: Breast cancer patients' decision making regarding oral endocrine therapy.

Sticking to the script: Breast cancer patients' decision making regarding oral endocrine therapy.
Wheeler, S.B., Roberts, M.C., Waters, A.R., Bloom, D., Peppercorn, J.,   Golin, C., Reeder-Hayes, K.E..
DOI: 10.1016/j.pec.2024.108349

by Sylvia Spengler-Mettler

Lattard et al. (2024). Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program.

Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program.

Lattard, C., Herledan, Ch., Reverdy, Th., Antherieu, G., Caffin, A.-G., Cerfon, M.-A., Maire, M., Rivat, R., France, St., Ghesquières, H., You, B., Freyer, G., Ranchon, F., Rioufol.
The Oncologist, oyae241, https://doi.org/10.1093/oncolo/oyae241

by Sylvia Spengler-Mettler

Bandiera et al. (2024). A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.

Bandiera, C., Cardoso, E., Locatelli, I., Zaman, K., Diciolla, A., Digklia, A., Stravodimou, A., Cristina, V., Aedo-Lopez, V., Dolcan, A., Sarivalasis, A., Bouchaab, H., Pasquier
https://doi.org/10.1093/oncolo/oyae241

by Sylvia Spengler-Mettler

Bright et al. (2023). A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors.

A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors.

Bright, E. E., Finkelstein, L. B., Nealis, M. S., Genung, S. R., Wrigley, J., Gu, H. C. J., Schmiege, S. J., & Arch, J. J. (2023). A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors. J Clin Oncol, 41(28), 4548-4561. https://doi.org/10.1200/JCO.23.00697

by Sylvia Spengler-Mettler

McGrady et al. (2023). Barriers to medication adherence among adolescents and young adults with cancer.

Zum Artikel

Barriers to medication adherence among adolescents and young adults with cancer.

McGrady, M. E., Ketterl, T. G., Norris, R. E., Perentesis, J. P., Pettee, D., Mara, C. A., Breen, G., & Pai, A. L. H. (2023). Barriers to medication adherence among adolescents and young adults with cancer. Pediatric Blood & Cancer, 70(3), 1-9. https://doi.org/10.1002/pbc.30186

by Sylvia Spengler-Mettler

Yussof et al. (2022). Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review.

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review.

Yussof, I., Mohd Tahir, N. A., Hatah, E., & Mohamed Shah, N. (2022). Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review. Breast, 62, 22-35. https://doi.org/10.1016/j.breast.2022.01.012

by Sylvia Spengler-Mettler